Schizophrenia is a serious disorder which affects how a person thinks, feels and acts. Someone with schizophrenia may have difficulty distinguishing between what is real and what is imaginary; may be unresponsive or withdrawn; and may have difficulty expressing normal emotions in social situations.
Our Scranton, PA site is currently enrolling subjects with Schizophrenia into research studies. Researchers are looking for subjects between the ages 18 and 64. The duration of the research study is between 52-78 weeks. All study related visits, laboratory work, study medication, and all study related procedures including physical exams are provided at no cost to those who qualify for study. Qualified participants will receive compensation for time and travel. Other criteria for eligibility will be discussed with interested persons, without obligation, when calling the telephone number of your nearest site. Please go to our contact page for ways to inquire about this study.
If you, or someone you know, suffers from Schizophrenia, you may be eligible to participate in a research study. Our studies seek to determine the safety and efficacy of an investigational drug for the treatment of those with the disease. For more information please contact us.
Our mission at Scranton Medical Institute (SMI) is to disseminate cutting-edge research to the people of Pennsylvania. We give you access to healthcare services that aren’t presently provided to the general public. Trials are entirely free, and people who take part may be compensated.
OFFICE HOURS:
Mon-Fri: 9:00 AM – 5:30 PM
Sat-Sun: Closed
CONTACT INFO:
Phone: 570-346-3686
Fax: 570-344-1085
ADDRESS:
340 Montage Mountain Road
Moosic, PA 18507